Loading clinical trials...

COMPLETEDPHASE4

Effect of Adding Sildenafil to Protocol of Endometrial Preparation in Outcome of Frozen-thawed Embryo Transfer Cycles

NCT01668446•farzaneh hojjat

Summary

The target of this study was an estimate the result of sildenafil on ultrasonographic endometrial thickness, endometrial pattern investigation estrogen level on the day of progesterone administration, Implantation rate and chemical pregnancy rate in frozen embryo transfer cycles .

Eligibility

Age

20 - 39 years

Sex

FEMALE

Healthy Volunteers

Yes

Inclusion Criteria

•women \> 40 years old,
•history of endocrine disease
•Hysteroscopic surgery
•cardiovascular, renal and liver disease
•hypotension( blood pressure \< 90/50)
•history of stroke or myocardial infarction
•use of alcohol or substance

Exclusion Criteria

•A total of 80 patients with antecedent of poor endometrial response and had frozen embryo included in this study all women must to be \< 40 years old,
•no history of endocrine disease,
•no Hysteroscopic surgery, had a high quality embryos no cardiovascular,
•renal and liver disease and
•no hypotension (blood pressure \< 90/50) or
•history of stroke or myocardial infarction and
•don't use of alcohol or substance Patients with these conditions enter this study and based on randomized tables are divided in two groups.

Locations (1)

Farzaneh Hojjat

Yazd, Iran

Key Dates

Start Date

September 1, 2009

Primary Completion Date

September 1, 2009

Completion Date

February 1, 2011

Last Updated

September 13, 2012

Enrollment

ACTUAL participants

Conditions

Endometrial PreparationFrozen Embryo Transfer

Interventions

Sildenafil

DRUG

estradiol valerat

DRUG

Relaxin Measurement in Different Endometrial Preparation Approaches for Frozen Embryo Transfer

NCT06526520

Frozen Embryo Transfer

View study

WITHDRAWNPHASE2

Benefit of Amlodipine in HRT Cycle for Frozen Embryo Transfer in the Correction of Uterine Pulsatility Index

NCT04954196

Frozen Embryo Transfer

View study

UNKNOWN

NEURODEVELOPMENTAL OUTCOMES OF SINGLETON CONCEIVED FROM FRESH AND FROZEN EMBRYO TRANSFER COMPARED WITH NATURALLY CONCEIVED

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 13, 2012Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions